3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow DA-1241: new trials by email Literature Review of DA-1241 trials Research Report on DA-1241
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH DA-1241, Sitagliptin, DA-1241 Placebo - NON-ALCOHOLIC STEATOHEPATITIS | Phase 2 | Completed | NeuroBo Pharmaceuticals Inc. | 109 | 2023-09-14 | 2024-11-14 |
| A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM DA-1241, Placebo, Sitagliptin - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Dong-A ST Co., Ltd. | 108 | 2018-08-29 | 2021-02-11 |
| A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects Placebo, Metformin, DA-1241 - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Dong-A ST Co., Ltd. | 60 | 2017-03-29 | 2017-11-20 |
Diabetes Mellitus, Type 2 (2) · Non-alcoholic Fatty Liver Disease (1)
Dong-A ST Co., Ltd. (2) · NeuroBo Pharmaceuticals Inc. (1)
United States (3)